BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Monday, March 2, 2026, at 4:30 p.m. E.T., to discuss its fourth quarter and full year 2025 financial results. Quanterix will issue a press release regarding its fourth quarter and full year 2025 financial results prior to the conference call on Monday, March 2, 2026. ...

Tech stocks continue to dominate the investing conversation on Wall Street – hardly a new development, but this month, the dialogue has turned slightly more bearish than what we’re used to. With the latest artificial intelligence (AI) models threatening to upend entire industries, investors are now chattering about the possibility of a “software Armageddon” that could wipe out legacy blue-chips. And up at the very top of the tech food chain, massive AI spending forecasts by the Magnificent 7 has revived ...

Core Viewpoint - Advanced Biomed Inc. announced a reverse stock split at a ratio of 1 for 20 shares, effective February 20, 2026, to comply with Nasdaq Listing Rule 5550(a)(2) [1][3]. Group 1: Reverse Stock Split Details - The reverse stock split was approved by a majority of the voting power on January 12, 2026, with the board finalizing the ratio on January 30, 2026 [2]. - The objective of the reverse split is to enable the company to meet the minimum bid price requirement of $1.00 per share on Nasdaq [3]. - Following the reverse split, the total issued and outstanding common shares will decrease from 27,290,710 to approximately 1,364,536 shares [6]. Group 2: Shareholder Impact - Each 20 shares will convert into one share, maintaining the par value of US$0.001, and will not alter stockholders' percentage ownership, except for minor changes due to fractional shares [4]. - No fractional shares will be issued; stockholders will receive one full share instead of any fractional share resulting from the split [5]. Group 3: Company Overview - Advanced Biomed Inc. is a biotechnology company focused on innovative biomedical products for precision medicine and advanced diagnostics [1][7]. - The company operates through a subsidiary in Taiwan and has developed a proprietary microfluidic platform for advanced circulating tumor cell detection and analysis [8].

转自：新华财经 2025年，嘉定汽车产业规模跨越3000亿元大关，上海汽车文化节拉动全要素旅游消费60.1亿元。上海国际汽车城（集团）有限公司透露，智能网联汽车发展 进入新阶段，已联合18家主流的乘用车车企和核心零部件企业，打造了汽车行业首个透明供应链管理平台；而更高级别的自动驾驶服务也正随着国家级L3 准入试点的推进，加速驶入市民生活。 2026年，嘉定将"加快打造世界智能网联新能源汽车创新高地"写入政府工作报告重点任务。上汽大众安亭基地转型升级按下快进键，高附加值、新能源车型 加速导入；"上汽系"新业务落地生根，固态动力电池量产在即，多元动力技术路线同步布局。高算力汽车芯片国产化进程也正全面提速，汽车正从交通工具 进化为有感知、会决策的智能终端。 展望"十五五"，嘉定将构建新型汽车产业生态体系，深化高级别自动驾驶引领区建设，推动电池再制造与梯度利用技术创新应用，让"世界智能网联新能源 汽车创新高地"从愿景变为实景。 芯耀北翼：集成电路全链自主攻坚突围 1058亿元，同比增长3.8%——这是2025年嘉定集成电路规上总产出交出的成绩单。作为上海集成电路产业"一体两翼"战略中的关键"北翼"，嘉定用五年时间 将 ...

在产业发展方面，该区域将承接南中轴地区和亦庄新城核心地区功能外溢，规划重点保障生物医药和商 业航天两大特色产业发展，助力国际科技创新中心功能建设。其中，生物医药产业以国际医药创新公园 为空间载体，商业航天产业以"北京火箭大街"项目为引擎。 本报讯（记者 陈雪柠）昨天，记者从市规划自然资源委获悉，《亦庄新城综合配套服务区YZ00—0401 —0405、0801—0805、0901—0905街区控制性详细规划（街区层面）（2020年—2035年）》获得批复。 《街区控规》明确，综合配套服务区定位为未来产业新引擎、生态宜居后花园，重点保障生物医药和商 业航天两大特色产业发展，助力亦庄新城打造"新质生产力典范区、国际一流高端产业综合新城"。 综合配套服务区位于亦庄新城西北部，西接南中轴及其延长线，东临亦庄新城核心地区，行政区划涉及 亦庄镇、旧宫镇和瀛海镇，包括15个街区，总用地面积约5761.97公顷。在生态景观方面，该区域将坚 持疏解与整治并举，推动城乡建设用地减量，提升绿色开敞空间占比，其中要以南海子公园为核心，打 造公园集群，完善文化休闲、户外体验、教育研学等配套设施，打造全龄友好休闲"后花园"。 ...

Group 1 - The core idea is to enhance the development capability of the Chengdu-Chongqing economic circle by establishing the Chengdu main axis economic corridor, the Cheng (Mian) Nan Da Wan economic belt, and the Minjiang-Changjiang upstream economic belt [1][2] - The government report emphasizes the importance of improving the comprehensive transportation system between Chengdu and Chongqing, and advancing the construction of the Chengdu-Chongqing high-speed rail and highway expansion projects [1][2] - The establishment of a regional technology innovation center in the Chengdu-Chongqing area aims to strengthen advanced manufacturing clusters in electronics and biomedicine [1][2] Group 2 - The discussion among representatives highlights the need to amplify Chengdu's radiating and driving role, which is seen as a crucial step in constructing a new pattern of regional coordinated development [2][3] - Collaboration between Chengdu and other cities, such as Mianyang and Nanchong, is essential for strengthening industrial cooperation and leveraging local resources [2][3] - The focus on infrastructure connectivity is underscored, with plans to enhance waterway transport and other major infrastructure projects to improve regional integration [3][4]

2月1日，上海浦东新区EKA天物空间创意园与虹口区瑞虹新天地太阳宫的商业气息持续被"广货"热潮所 点燃，"广货行天下·中山百货进上海"活动持续升温。 在瑞虹新天地太阳宫，广东威力电器展台上，一台机身泛黄、标识仍清晰的1984年产威力牌半自动洗衣 机，唤醒了许多上海参观者的集体记忆。上海市民余先生回忆，上世纪80年代末他家里购入一台威力双 缸洗衣机，"用了快20年，核心部件从没出过大问题"。2012年装修新房时，出于对这份"长期陪伴"的信 赖，他再次选择了一台威力洗衣机，使用至今。 威力电器电商运营经理余元江告诉记者，在威力洗衣机风靡的年代，上海市场销量一度占全国的近五分 之一。此次参展，广东威力电器有限公司在"老古董"旁陈列了针对上海梅雨天气、小户型空间、静音需 求精准研发的洗烘一体机、超薄静音机和迷你母婴洗衣机。从"用了20年没坏"的口碑，到"为上海定 制"的创新，威力电器与上海消费者的故事生动演绎了"广货"与上海市场的双向奔赴。 主办方提供的数据显示，活动期间，中山与上海两地企业、机构共达成超百个合作签约项目，总金额超 60亿元，其中产品购销合作额占比近一半。值得一提的是，仅中山古镇灯饰企业雷士光电、松伟 ...

Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. regarding a securities fraud class action settlement, focusing on potential breaches of fiduciary duties by certain officers and directors [1][3]. Group 1: Settlement Details - A federal securities class action against Lifecore Biomedical and certain officers has reached a settlement of $3,750,000 [4]. - Shareholders who held shares before October 7, 2020, can seek corporate reforms, return of funds, and a court-approved incentive award at no cost [2][5]. Group 2: Allegations Against Lifecore - The class action complaint alleges that Lifecore made materially false and misleading statements about its business, operations, and prospects [3]. - Specific allegations include deficient internal controls over financial reporting, inaccurate financial statements requiring restatement, ineffective remediation efforts, and impaired ability to file periodic reports with the SEC [3].

Core Insights - The Yangtze River Delta region is witnessing a significant increase in the number of cities with a GDP exceeding 1 trillion yuan, reaching a total of 10 by 2025, with Shanghai leading at 5.67 trillion yuan [1][2] - The focus of urban competition is shifting from merely achieving a trillion GDP to enhancing the quality and sustainability of economic growth, emphasizing innovation, industrial structure, and living standards [2][6] Economic Data Summary - Shanghai's GDP is projected to be 5.67 trillion yuan with a growth rate of 5.4% in 2025 [1][3] - Suzhou's GDP is expected to reach 2.77 trillion yuan, while Nanjing is approaching the 2 trillion yuan mark [2][4] - Hangzhou's GDP is estimated at 2.3 trillion yuan, with a growth rate of 5.2% [1][3] - Ningbo's GDP is projected at 1.87 trillion yuan, growing at 4.9% [1][4] - Wenzhou has recently crossed the 1 trillion yuan threshold, achieving a GDP of 1.02 trillion yuan with a growth rate of 6.1% [1][5] Industrial Development Trends - Shanghai is focusing on high-end industrial clusters, with significant growth in advanced manufacturing sectors such as integrated circuits (15.1% growth) and artificial intelligence (13.6% growth) [3][8] - Hangzhou is emphasizing the integration of digital economy with advanced manufacturing, with notable growth in new energy vehicles and industrial robots [4][9] - Suzhou is transitioning from traditional manufacturing to a modern industrial system, targeting sectors like biomedicine and high-end medical devices [8][10] - Wenzhou's economic growth is driven by its manufacturing sector, with strategic emerging industries and high-tech sectors showing substantial growth [5][11] Future Industry Layout - Cities in the Yangtze River Delta are actively planning for future industries, focusing on sectors like quantum technology, synthetic biology, and advanced semiconductor materials [10][11] - The competition among cities is increasingly defined by their ability to innovate and create sustainable industrial ecosystems rather than just GDP figures [6][7] Long-term Competitiveness Factors - Key variables for long-term competitiveness include the originality and resilience of industrial ecosystems, efficiency in innovation and technology transfer, and the ability to attract and retain talent [11][12] - Cities are encouraged to create favorable living conditions and cultural experiences to enhance their attractiveness to talent [11]

Core Insights - Curative Biotechnology, Inc. has received a Notice of Allowance for a Canadian patent related to a novel pharmacological target for treating retinal degeneration, which is a significant advancement for the company [1][3] - The company holds an exclusive worldwide license for this technology from the National Eye Institute, indicating a strong partnership with a reputable institution [1][6] - Curative plans to expand its metformin-based eye drop program into veterinary applications, specifically targeting canine retinal degenerative diseases, which may enhance the overall value of its platform [4][5] Intellectual Property - The Canadian patent includes 22 allowed claims focused on topical ocular delivery methods relevant to metformin-based formulations, aligning with the company's intended administration route [3] - The patent is expected to be formally issued in the coming months, further solidifying the company's intellectual property portfolio [3] Development Plans - Curative's primary focus is on developing a metformin-based reformulation for treating intermediate and late-stage Age-Related Macular Degeneration (AMD), with a first-in-human clinical trial planned for 2026 [6] - The company is also exploring parallel development pathways in veterinary ophthalmology, addressing unmet needs in canine retinal diseases [4][5]